POSTMORTEM PROOF OF EFFECTIVENESS OF ZONA INCERTA STIMULATION IN PARKINSON DISEASE
Citation Manager Formats
Make Comment
See Comments
![Loading Loading](https://n.neurology.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
High frequency stimulation (HFS) of the subthalamic nucleus (STN) is recognized as a therapeutic choice for advanced forms of Parkinson disease (PD) with motor fluctuations.1 However, the location of the best target remains a matter of debate. Although the STN is considered as the gold standard, good therapeutic results have been obtained using electrode contacts located outside the STN, within adjacent structures such as the zona incerta (ZI).2–4 In this study, we report the first pathologically proven case of direct bilateral ZI stimulation which dramatically improved the cardinal symptoms of PD in a patient implanted for severe PD 6 years previously and who suddenly died.
Clinical data.
A 52-year-old man was proposed deep brain stimulation (DBS) because he had severe PD for 13 years that had reached the stage of motor fluctuations with incapacitating levodopa-induced dyskinesia. He was operated under local anesthesia. Peroperative single-unit activity recordings could not be completed in this patient for technical reasons. However, the surgical procedure was the same as that used for patients reported in a previous article.5 The position of the active contacts was determined in relation to the mid-commisural point and revealed that the right electrode was located more anteriorly and less deep compared to the left one. In this article, we focus on the …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Alert Me
Recommended articles
-
Articles
Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson diseaseA. Sailer, D. I. Cunic, G. O. Paradiso et al.Neurology, January 29, 2007 -
Articles
STN-DBS activates the target area in Parkinson diseaseAn FDG-PET studyR. Hilker, J. Voges, T. Weber et al.Neurology, July 23, 2008 -
Views and Reviews
A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PDR.J. St. George, J.G. Nutt, K.J. Burchiel et al.Neurology, October 04, 2010 -
Articles
Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulationR. Kumar, A.M. Lozano, E. Sime et al.Neurology, August 01, 1999